Delivery Order SPE2DB22D2206-SPE2DB25FKD18
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count packaging, valued at $2,254.12. This is a firm fixed-price delivery order with no set-aside designation, issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-unit packaging, with a ceiling value of $2,729.80. This non-set-aside, competitively awarded delivery order represents a firm fixed price contract with performance scheduled for completion by August 13, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 36,000 unit capsules of Creon DR 100s with a ceiling value of $58,274.04. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, valued at $31,396.02. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for 36,000 units of Creon DR 100s capsules with a ceiling value of $5,071.22. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on September 4, 2025, with a ceiling value of $1,616.16 and completion date of September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Creon DR 24,000 unit capsules in quantities of 100s, with a ceiling value of $2,781.34. This is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $5,467.17. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is performable at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100s, with a contract ceiling value of $11,387.51. This is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Creon DR 24,000 unit capsules (100 count) with a ceiling value of $2,262.52 and an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKD18Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of 36,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This is a firm fixed-price delivery order with a ceiling value of $9,357.21 and an ultimate completion date of September 29, 2025. The contract is not set-aside and represents a competitive award. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania, which serves as both the company headquarters and place of performance for this federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through this prime contract vehicle, supplying a broad range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The delivery order for Creon capsules reflects the company's ongoing role in supporting military and federal healthcare supply chains with essential medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/26/25 |